Paper19476397
Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis.
Díaz-Borjón A. Drugs Aging, 2009. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis. Papers, record 19476397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19476397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antirheumatic Agents | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Immunologic Factors | Major topic |
| Aged | |
| Aging | |
| Humans | |
| Practice Guidelines as Topic |
Source PubMed
References179
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16258899 | Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. | Arthritis Rheum | 2005 | https://conductscience.org/library/papers/16258899 | PubMed |
| 2 | 14616975 | High prevalences of vitamin B12 and folic acid deficiency in elderly subjects in Israel. | Br J Haematol | 2003 | https://conductscience.org/library/papers/14616975 | PubMed |
| 3 | 15552522 | Benefit/risk of cyclosporine in rheumatoid arthritis. | Clin Exp Rheumatol | 2004 | https://conductscience.org/library/papers/15552522 | PubMed |
| 4 | 6881184 | Hydroxychloroquine in the treatment of rheumatoid arthritis. | Am J Med | 1983 | https://conductscience.org/library/papers/6881184 | PubMed |
| 5 | 17655372 | Clinical pharmacokinetics and use of infliximab. | Clin Pharmacokinet | 2007 | https://conductscience.org/library/papers/17655372 | PubMed |
| 6 | 1977391 | The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. | Arthritis Rheum | 1990 | https://conductscience.org/library/papers/1977391 | PubMed |
| 8 | 9929017 | Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. | Lancet | 1999 | https://conductscience.org/library/papers/9929017 | PubMed |
| 9 | 15264435 | Technology evaluation: abatacept, Bristol-Myers Squibb. | Curr Opin Mol Ther | 2004 | https://conductscience.org/library/papers/15264435 | PubMed |
| 10 | 2112243 | Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials. | Pharmacotherapy | 1990 | https://conductscience.org/library/papers/2112243 | PubMed |
| 11 | 1920331 | The effect of age on methotrexate efficacy and toxicity. | J Rheumatol | 1991 | https://conductscience.org/library/papers/1920331 | PubMed |
| 12 | 15082480 | Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. | Ann Rheum Dis | 2004 | https://conductscience.org/library/papers/15082480 | PubMed |
| 13 | 4037555 | Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. | Ann Intern Med | 1985 | https://conductscience.org/library/papers/4037555 | PubMed |
| 14 | 14963199 | Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. | Rheumatology (Oxford) | 2004 | https://conductscience.org/library/papers/14963199 | PubMed |
| 15 | 6869410 | Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. | Am J Med | 1983 | https://conductscience.org/library/papers/6869410 | PubMed |
| 16 | 6813481 | The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis. | J Rheumatol Suppl | 1982 | https://conductscience.org/library/papers/6813481 | PubMed |
| 17 | 3883172 | Efficacy of low-dose methotrexate in rheumatoid arthritis. | N Engl J Med | 1985 | https://conductscience.org/library/papers/3883172 | PubMed |
| 18 | 1747702 | Should disease-modifying agents be used in mild rheumatoid arthritis? | Br J Rheumatol | 1991 | https://conductscience.org/library/papers/1747702 | PubMed |
| 19 | 11034720 | Azathioprine for treating rheumatoid arthritis. | Cochrane Database Syst Rev | 2000 | https://conductscience.org/library/papers/11034720 | PubMed |
| 20 | 2896459 | Sulfasalazine: II. Some notes on the discovery and development of salazopyrin. | Am J Gastroenterol | 1988 | https://conductscience.org/library/papers/2896459 | PubMed |
| 21 | 7352462 | The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. | Am J Epidemiol | 1980 | https://conductscience.org/library/papers/7352462 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39914430 | Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG). | Lancet Oncol | 2025 | https://conductscience.org/library/papers/39914430 | PubMed |
| 39712845 | Clinical Characteristics of Young-Onset Versus Elderly-Onset Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. | Cureus | 2024 | https://conductscience.org/library/papers/39712845 | PubMed |
| 39583861 | How Were the Elderly RA Patients Doing Over the Past Year?-A Post Hoc Analysis for Telephone Based Following Up to RA Patients in Zunyi China. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/39583861 | PubMed |
| 37856034 | Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry. | Rheumatol Ther | 2023 | https://conductscience.org/library/papers/37856034 | PubMed |
| 36104655 | Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients. | Drugs Aging | 2022 | https://conductscience.org/library/papers/36104655 | PubMed |
| 33205322 | Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort Study. | Drugs Aging | 2020 | https://conductscience.org/library/papers/33205322 | PubMed |
| 33078092 | Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis. | Acta Pharm Sin B | 2020 | https://conductscience.org/library/papers/33078092 | PubMed |
| 28224284 | Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the Pharmacological Management of Elderly Patients. | Drugs Aging | 2017 | https://conductscience.org/library/papers/28224284 | PubMed |
| 26123949 | Diagnosis and Management of Late-Onset Spondyloarthritis: Implications of Treat-to-Target Recommendations. | Drugs Aging | 2015 | https://conductscience.org/library/papers/26123949 | PubMed |
| 24676590 | [Safety of antirheumatic drug treatment in the elderly]. | Z Rheumatol | 2014 | https://conductscience.org/library/papers/24676590 | PubMed |
| 24197607 | Elderly-onset sarcoidosis: prevalence, clinical course, and treatment. | Drugs Aging | 2013 | https://conductscience.org/library/papers/24197607 | PubMed |
| 24105334 | Rheumatoid arthritis in the elderly in the era of tight control. | Drugs Aging | 2013 | https://conductscience.org/library/papers/24105334 | PubMed |
| 23509636 | Clinical and radiological presentations of late-onset spondyloarthritis. | ISRN Rheumatol | 2011 | https://conductscience.org/library/papers/23509636 | PubMed |
| 21124693 | Pattern of Young and Old Onset Rheumatoid Arthritis (YORA and EORA) Among a Group of Egyptian Patients with Rheumatoid Arthritis. | Clin Med Insights Arthritis Musculoskelet Disord | 2010 | https://conductscience.org/library/papers/21124693 | PubMed |
| 20583847 | Late-onset ankylosing spondylitis and spondylarthritis: an update on clinical manifestations, differential diagnosis and pharmacological therapies. | Drugs Aging | 2010 | https://conductscience.org/library/papers/20583847 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19476397
GET https://conductscience.org/api/papers/v1/19476397/references?page=2